FI964463A0 - Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina - Google Patents

Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina

Info

Publication number
FI964463A0
FI964463A0 FI964463A FI964463A FI964463A0 FI 964463 A0 FI964463 A0 FI 964463A0 FI 964463 A FI964463 A FI 964463A FI 964463 A FI964463 A FI 964463A FI 964463 A0 FI964463 A0 FI 964463A0
Authority
FI
Finland
Prior art keywords
nitric oxide
inhibitors
oxide synthetase
formula
amidine derivatives
Prior art date
Application number
FI964463A
Other languages
English (en)
Swedish (sv)
Other versions
FI964463A (fi
Inventor
James Edwin Macdonald
William Calvin Shakespeare
Robert John Murray
James Russell Matz
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB9409201A external-priority patent/GB9409201D0/en
Priority claimed from GB9409462A external-priority patent/GB9409462D0/en
Application filed by Astra Ab filed Critical Astra Ab
Publication of FI964463A0 publication Critical patent/FI964463A0/fi
Publication of FI964463A publication Critical patent/FI964463A/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/04—Drugs for genital or sexual disorders; Contraceptives for inducing labour or abortion; Uterotonics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Pregnancy & Childbirth (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Rheumatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Transplantation (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FI964463A 1994-05-07 1996-11-06 Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina FI964463A (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9409201A GB9409201D0 (en) 1994-05-07 1994-05-07 Pharmaceutically active compounds
GB9409462A GB9409462D0 (en) 1994-05-12 1994-05-12 Pharmaceutically active compounds
PCT/GB1995/001041 WO1996001817A1 (en) 1994-05-07 1995-05-09 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase

Publications (2)

Publication Number Publication Date
FI964463A0 true FI964463A0 (fi) 1996-11-06
FI964463A FI964463A (fi) 1996-11-06

Family

ID=26304851

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964463A FI964463A (fi) 1994-05-07 1996-11-06 Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina

Country Status (15)

Country Link
US (2) US5807886A (fi)
EP (1) EP0759027B1 (fi)
JP (1) JPH10500138A (fi)
AT (1) ATE182889T1 (fi)
AU (1) AU682768B2 (fi)
CA (1) CA2188680A1 (fi)
DE (1) DE69511260T2 (fi)
DK (1) DK0759027T3 (fi)
ES (1) ES2137512T3 (fi)
FI (1) FI964463A (fi)
GR (1) GR3031693T3 (fi)
HK (1) HK1009043A1 (fi)
MX (1) MX9605366A (fi)
NO (1) NO964698L (fi)
WO (1) WO1996001817A1 (fi)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10500129A (ja) * 1994-05-11 1998-01-06 ジェス、オルセン 片頭痛の治療におけるｎｏスカベンジャー、阻害剤または拮抗剤の使用
BR9509297A (pt) * 1995-08-10 1998-07-07 Astra Ab Composto composição farmacêutica utilização de um composto e processos de tratamento ou prolifaxia de uma doença ou condição na qual a síntese ou suprasintese da sintetase de óxido nitrico forma uma parte contribuinte e desordens neurodegenerativas ou de enxaqueca ou de prevenção e reversão da tolerância a opiatos e diazepinas ou de tratamento do vicio em tóxicos e de preparação de um composto
JP2000511173A (ja) * 1996-05-27 2000-08-29 藤沢薬品工業株式会社 一酸化窒素産生阻害剤としての新規なインドリルおよびベンゾフラニルカルボキサミド
US6335445B1 (en) 1997-03-24 2002-01-01 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Derivatives of 2-(iminomethyl)amino-phenyl, their preparation, their use as medicaments and the pharmaceutical compositions containing them
FR2761066B1 (fr) * 1997-03-24 2000-11-24 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2764889B1 (fr) * 1997-06-20 2000-09-01 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
SE9701681D0 (sv) * 1997-05-05 1997-05-05 Astra Ab New compounds
SE9701682D0 (sv) * 1997-05-05 1997-05-05 Astra Ab Compounds
WO1999057114A1 (en) * 1998-05-04 1999-11-11 Fujisawa Pharmaceutical Co., Ltd. Heterocyclic carboxamide derivatives as inhibitors of nitric oxide production
EP1085846A2 (en) * 1998-06-08 2001-03-28 Advanced Medicine, Inc. Multibinding inhibitors of microsomal triglyceride transferase protein
FR2783519B1 (fr) 1998-09-23 2003-01-24 Sod Conseils Rech Applic Nouveaux derives d'amidines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
FR2784678B1 (fr) * 1998-09-23 2002-11-29 Sod Conseils Rech Applic Nouveaux derives de n-(iminomethyl)amines, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
WO2001087834A1 (fr) * 2000-05-16 2001-11-22 Takeda Chemical Industries, Ltd. Antagoniste de l'hormone de concentration de la melanine
PE20020856A1 (es) 2001-02-13 2002-11-11 Aventis Pharma Gmbh 1,2,3,4-tetrahidronaftil aminas aciladas
US7232822B2 (en) * 2001-10-12 2007-06-19 Choongwae Pharma Corporation Reverse-turn mimetics and method relating thereto
NZ535366A (en) * 2002-03-13 2007-07-27 Univ Tennessee Res Foundation Substituted tetrahydroisoquinoline compounds, methods of making, and their use
US8173813B2 (en) * 2007-03-23 2012-05-08 Neuraxon, Inc. Quinolone and tetrahydroquinolone and related compounds having NOS inhibitory activity

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL135043C (fi) * 1963-10-11
GB1145278A (en) * 1964-07-07 1969-03-12 Wellcome Found Amidine derivatives, processes for their preparation, and compositions incorporating them
GB1180629A (en) * 1967-07-14 1970-02-04 Delalande Sa Di-Amidines derived from Aromatic Diamines and process for obtaining same
GB1188956A (en) * 1967-07-14 1970-04-22 Delalande Sa N-Substituted Aromatic Amidines and process for obtaining same
US3669974A (en) * 1971-03-25 1972-06-13 Usv Pharma Corp N,n1-disubstituted benzamidines
DE2321330A1 (de) * 1973-04-27 1974-11-07 Bayer Ag Azolyl-amidine, verfahren zu ihrer herstellung sowie ihre verwendung als herbizide
JPS5246949B2 (fi) * 1973-10-19 1977-11-29
US3903163A (en) * 1974-10-02 1975-09-02 Dow Chemical Co N,N-Disubstituted naphthaleneacetamidines
US4073639A (en) * 1975-01-06 1978-02-14 United Technologies Corporation Metallic filler material
IE62023B1 (en) * 1989-01-02 1994-12-14 Boots Co Plc Therapeutic agents
CA2036770C (en) * 1990-02-26 2003-09-09 Jeffrey P. Whitten Inhibitors of nitric oxide biosynthesis
CA2089261A1 (en) * 1990-08-30 1992-03-01 John F.W. Keana Substituted amidines having high binding to the sigma receptor and the use thereof
JP3251673B2 (ja) * 1991-12-16 2002-01-28 ワシントン ユニバーシティー 酸化窒素生成の抑制方法
US5246971A (en) * 1991-12-16 1993-09-21 Washington University Method of inhibiting nitric oxide formation
WO1993013066A1 (en) * 1991-12-20 1993-07-08 Syntex (U.S.A.) Inc. Cyclic amides of 3-amino-2-hydroxy-carboxylic acids as hiv-protease inhibitors
GB9127376D0 (en) * 1991-12-24 1992-02-19 Wellcome Found Amidino derivatives
GB9200114D0 (en) * 1992-01-04 1992-02-26 Scras Dual inhibitors of no synthase and cyclooxygenase
US5281627A (en) * 1992-05-28 1994-01-25 Cornell Research Foundation, Inc. Substituted arginines and substituted homoarginines and use thereof
US5362747A (en) * 1992-11-25 1994-11-08 Abbott Laboratories 2-nitroaryl and 2-cyanoaryl compounds as regulators of nitric oxide synthase
WO1994012165A2 (en) * 1992-11-27 1994-06-09 The Wellcome Foundation Limited Enzyme inhibitors
WO1994021621A1 (en) * 1993-03-23 1994-09-29 Astra Aktiebolag Guanidine derivatives useful in therapy
GB9312761D0 (en) * 1993-06-21 1993-08-04 Wellcome Found Amino acid derivatives
ATE231126T1 (de) * 1993-08-12 2003-02-15 Astrazeneca Ab Amidin-derivate mit stickstoffoxid-synthease- aktivität
AU7705694A (en) * 1993-10-04 1995-05-01 Glaxo Wellcome House Substituted urea and isothiourea derivatives as no synthase inhibitors
GB9320484D0 (en) * 1993-10-05 1993-11-24 Wellcome Found Pharmaceutical combinations
EP0676196A1 (en) * 1993-10-13 1995-10-11 Otsuka Pharmaceutical Co., Ltd. Nitrogen monoxide synthesis inhibitor
PT724435E (pt) * 1993-10-21 2002-11-29 Searle & Co Derivados amidino uteis como inibidores de oxido nitrico sintase
CN1077886C (zh) * 1993-10-21 2002-01-16 G·D·瑟尔公司 用作一氧化一氮合酶抑制剂的脒基衍生物
US5629322A (en) * 1994-11-15 1997-05-13 Merck & Co., Inc. Cyclic amidine analogs as inhibitors of nitric oxide synthase

Also Published As

Publication number Publication date
EP0759027A1 (en) 1997-02-26
EP0759027B1 (en) 1999-08-04
GR3031693T3 (en) 2000-02-29
ATE182889T1 (de) 1999-08-15
CA2188680A1 (en) 1996-01-25
ES2137512T3 (es) 1999-12-16
US6117898A (en) 2000-09-12
AU682768B2 (en) 1997-10-16
NO964698D0 (no) 1996-11-06
HK1009043A1 (en) 1999-05-21
WO1996001817A1 (en) 1996-01-25
NO964698L (no) 1996-11-06
US5807886A (en) 1998-09-15
DE69511260D1 (en) 1999-09-09
DK0759027T3 (da) 2000-03-27
AU2413995A (en) 1996-02-09
JPH10500138A (ja) 1998-01-06
DE69511260T2 (de) 2000-03-16
FI964463A (fi) 1996-11-06
MX9605366A (es) 1997-12-31

Similar Documents

Publication Publication Date Title
FI964463A (fi) Bisykliset amidiinijohdannaiset typpioksidinsyntetaasin inhibiittoreina
BG95818A (en) Herbicides
ATE227719T1 (de) Heteroaryl-zyklische acetale
NZ503912A (en) Piperidinylaminomethyl trifluoromethyl cyclic ether compounds and their use as substance P antagonists
MY104850A (en) N-phenyloyrazole derivatives
IE802684L (en) Quinoline derivatives
DE3776044D1 (de) Pyridazinon-derivate.
DK0662971T3 (da) 5H,10H-Imidazo[1,2-a]indeno[1,2-e]pyrazin-4-on-derivater, fremstilling af disse forbindelser samt lægemidler indeholdende f
NO961404L (no) 4-indolylpiperazinyl-derivater
AU590030B2 (en) Antihypertensive combination product
WO2000005224A3 (en) Heterocyclic derivatives and their use as integrin inhibitor
TW429147B (en) Pharmaceutical composition for the treatment of CNS disorders
DK0471493T3 (da) N,N,N-Trisubstituerede-5-bisaminomethylen-1,3-dioxan-4,6-dioner som inhibitorer af acyl-CoA:cholesterol-acyltransferase
AU547599B2 (en) Tricyclic compounds
ES496423A0 (es) Un procedimiento para la preparacion de nuevos derivados de aminoalquilbenzofurano.
FI854343A (fi) Foerfarande foer framstaellning av 3-amino-2,3-dihydro-1-benzoxepinfoereningar.
MY102128A (en) Phenoxybenzamide derivatives, their preparation and herbicidal compositions containing them
DK44779A (da) 2-chlorsulfinylazetidin-4-on-forbindelser til anvendelse som mellemprodukter ved fremstilling af 3-exomethylencephamsulfoxider